Peter Oluwaseyi Robert Warner
Career history of Peter Oluwaseyi Robert Warner
Former positions of Peter Oluwaseyi Robert Warner
| Companies | Position | Start | End |
|---|---|---|---|
| ANIMALCARE GROUP PLC | Director/Board Member | 2011-12-30 | 2011-12-30 |
| Director of Finance/CFO | - | 2011-12-30 | |
| Corporate Secretary | - | 2011-12-30 | |
Animalcare Ltd.
 Animalcare Ltd. Pharmaceuticals: MajorHealth Technology Part of Animalcare Group Plc, Animalcare Ltd. develops and sells licensed veterinary pharmaceutical products. The company is based in York, UK. Animalcare was founded in 1988. Animalcare was acquired by Ritchey Plc from Genus Plc on January 15, 2008 for $28.95 million. | Comptroller/Controller/Auditor | 2005-12-31 | - |
VDC Plc
 VDC Plc Pharmaceuticals: MajorHealth Technology Part of Genus Plc, VDC Plc is a British company that supplies drugs and instruments to the veterinary profession. The company is based in York, UK. VDC was acquired by Genus Plc on August 19, 1999 for $41.49 million. | Comptroller/Controller/Auditor | 1995-12-31 | - |
Statistics
International
| United Kingdom | 4 |
Operational
| Comptroller/Controller/Auditor | 2 |
| Director/Board Member | 1 |
| Director of Finance/CFO | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ANIMALCARE GROUP PLC | Health Technology |
| Private companies | 2 |
|---|---|
VDC Plc
VDC Plc Pharmaceuticals: MajorHealth Technology Part of Genus Plc, VDC Plc is a British company that supplies drugs and instruments to the veterinary profession. The company is based in York, UK. VDC was acquired by Genus Plc on August 19, 1999 for $41.49 million. | Health Technology |
Animalcare Ltd.
Animalcare Ltd. Pharmaceuticals: MajorHealth Technology Part of Animalcare Group Plc, Animalcare Ltd. develops and sells licensed veterinary pharmaceutical products. The company is based in York, UK. Animalcare was founded in 1988. Animalcare was acquired by Ritchey Plc from Genus Plc on January 15, 2008 for $28.95 million. | Health Technology |
